CatalystPit

ABSIAbsci Corp

NASDAQ · Services-Commercial Physical & Biological Research
Last close $10.77 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorIndustrials
IndustryServices-Commercial Physical & Biological Research
Market cap$1.85B
RECENT INSIDER TRADES
  • 2026-09-01 · Jonasson Zachariah (CFO / CBO) · OTHER
  • 2026-07-06 · Szela Mary T (Director) · BUY
  • 2026-06-11 · MCGINNIS KAREN K (Director) · OTHER
  • 2026-06-08 · Rabinovitsj Daniel A (Director) · OTHER
  • 2026-06-08 · Szela Mary T (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders212
Shares held166,335,754
Value$1.78B
Percent of shares outstanding96.92%
As of quarter end2026-06-30
RECENT NEWS
  • Guggenheim reiterates Absci stock rating on endometriosis trial delay
  • Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
  • Absci presents at Morgan Stanley's 24th Annual Global Healthcare Conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS